Male and Female Breast Cancer – Differences in DNA Ploidy, p21 and p53 Expression Reinforce the Possibility of Distinct Pathways of Oncogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Male and Female Breast Cancer – Differences in DNA Ploidy, p21 and p53 Expression Reinforce the Possibility of Distinct Pathways of Oncogenesis

Published:2007 Issue:6 Volume:74 Page:323-327
ISSN:1015-2008
Container-title:Pathobiology
language:en
Short-container-title:Pathobiology

Author:

André Saudade,Pinto António E.,Laranjeira Cátia,Quaresma Manuela,Soares Jorge

Publisher

S. Karger AG

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Reference30 articles.

1. Male Versus Female Breast Cancers

2. A Review of the Diagnosis and Management of Male Breast Cancer

3. Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay

4. p21Waf1/Cip1 as a therapeutic target in breast and other cancers

5. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review;The Lancet Oncology;2023-02

2. Male breast cancer: Specific biological characteristics and survival in a Portuguese cohort;Molecular and Clinical Oncology;2019-04-08

3. Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database;Breast Cancer Research and Treatment;2018-05-28

4. Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review;Anticancer Research;2018-01-02

5. Male Breast Cancer; A Review of Risk Factors and Clinical and Radiological Features;Multidisciplinary Cancer Investigation;2017-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3